CML

01-Dec-2009

 

Home
CML A Quest for Answers 2004 10 27.pdf
New Strategies
Emerging Therapies
Monitoring CML

 

 

 

INDEX

 

What is chronic myeloid leukemia?

Chronic myeloid leukemia (also called CML or chronic granulocytic leukemia) is a disease in which too many white blood cells are made in the bone marrow. The bone marrow is the spongy tissue inside the large bones in the body. The bone marrow makes red blood cells (which carry oxygen and other materials to all tissues of the body), white blood cells (which fight infection), and platelets (which make the blood clot). Normally, bone marrow cells called blasts develop into several different types of blood cells that have specific jobs to do in the body. CML affects the blasts that are developing into white blood cells called granulocytes. The blasts do not mature and become too numerous. These immature blast cells are then found in the blood and the bone marrow. In most people with CML, the genetic material (chromosomes) in the leukemia cells have an abnormal feature called a Philadelphia chromosome. This chromosome usually doesn't go away, even after treatment. Leukemia can be acute (progressing quickly with many immature blasts) or chronic (progressing slowly with more mature-looking cancer cells). Chronic myeloid leukemia progresses slowly and usually occurs in people who are middle-aged or older, although it can also occur in children. In the first stages of CML, most people don't have any symptoms of cancer. A doctor should be seen if any of the following symptoms appear: tiredness that won't go away, a feeling of no energy, fever, not feeling hungry, or night sweats. Also, the spleen (the organ in the upper abdomen that makes other types of white blood cells and filters old blood cells from the blood) may be swollen.

If there are symptoms, a doctor may order blood tests to count the number of each of the different kinds of blood cells. If the results of the blood test are not normal, the doctor may order more blood tests. A bone marrow biopsy may also be done. During this test, a needle is inserted into a bone and a small amount of bone marrow is taken out and looked at under the microscope. The doctor can then tell what kind of leukemia the patient has and plan the best treatment.

Go to top

 

Stage Explanation

Stages of chronic myeloid leukemia. Once chronic myeloid leukemia (CML) has been diagnosed, more tests may be done to find out if leukemia cells have spread into other parts of the body such as the brain. This is called staging. CML progresses through different phases and these phases are used to plan treatment. The following stages are used for chronic myeloid leukemia:

Chronic phase

There are few blast cells in the blood and bone marrow and there may be no symptoms of leukemia. This phase may last from several months to several years.

Accelerated phase

There are more blast cells in the blood and bone marrow, and fewer normal cells.

Blastic phase

More than 30 % of the cells in the blood or bone marrow are blast cells. The blast phase of CML is sometimes called "blast crisis." Sometimes blast cells will form tumors outside of the bone marrow in places such as the bone or lymph nodes. Lymph nodes are small bean-shaped structures that are found throughout the body. They produce and store infection-fighting cells.

Refractory

Leukemia cells do not decrease even though treatment is given.

This article is from the PDQ, which is a service of the National Cancer Institute.

Go to top

 

Contact
The Leukemia & Lymphoma Society
1311 Mamaroneck Ave.
White Plains, NY 10605

or call the Information Resource Center at (800) 955-4572. 

Go to top

Helpful Links

  • National Cancer Institute
    This site offers comprehensive information about cancers and the diagnosis procedures.
  • Medicine Online
    This site offers information about diagnosis and treatment (including immunotherapy), with pages written by several physicians. Go to "cancer links/leukemia/current" .

Go to top

CML Medical Monitor

The CML Medical Monitor was developed to help people living with chronic myeloid leukemia keep track of their symptoms and treatment progress. It was designed in collaboration with CML medical experts and patients like you.

We want you to get the most you can out of this valuable resource, so we thought we would highlight some of the features of the tracking tool. In this issue, we will tell you how to take advantage of the "Ask the Experts" feature, as well as the "Education" and "Resources" sections.

Ask the Experts
The "Ask the Experts" section of the CML Medical Monitor enables you to submit questions about CML to our roster of experts, which includes leading doctors and nurses in the CML field. You may also view questions and answers that have previously been submitted—just click on the question you are interested in. Some recent questions include queries about lab report information, and CML medication usage and side effects.

Education and Resources
In the CML Medical Monitor "Education" page, you will find an ever-growing library of CML information. Our library is a rich resource featuring educational videos, articles and "Ask Your Doctor" handouts that will help you learn more about topics regarding CML. You can print out the "Ask Your Doctor" handouts and take them with you to the doctor's office. That way you will have a handy reference that offers a list of suggested questions, as well as a brief explanation of why knowing the answers to these questions will help you become a more knowledgeable and empowered patient.

The "Resources" section offers a list of organizations devoted to people living with leukemia and/or other kinds of cancer. Descriptions of each group are included, as well as links to each organization's Web site.

To see these features in action, you'll first need to log on to the CML Medical Monitor at: www.cmlmedicalmonitor.com. Once you're logged in, follow the links for more on the "Ask the Experts," the "Education," and the "Resources" features of the CML Medical Monitor. Check back often as we will continue to update these features.

The CML Medical Monitor is supported through an unrestricted educational grant from Novartis Oncology.

If you have any questions or comments about the CML Medical Monitor, please email us at: info@cmlmedicalmonitor.com.

Go to top

Contact us at johan@maartenspro.com

 

Home | CML A Quest for Answers 2004 10 27.pdf | New Strategies | Emerging Therapies | Monitoring CML

This site was last updated 12/01/09